3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Brain Neoplasms
41
Carcinoma, Non-Small-Cell Lung
35
Neoplasm Metastasis
32
Pancreatic Neoplasms
30
Prostatic Neoplasms
24
Lung Neoplasms
21
Carcinoma, Hepatocellular
21
Melanoma
16
Breast Neoplasms
12
Liver Neoplasms
10
Glioblastoma
10
Squamous Cell Carcinoma of Head and Neck
8
Carcinoma, Renal Cell
8
Neoplasms
7
Head and Neck Neoplasms
7
Kidney Neoplasms
6
Gliosarcoma
6
Sarcoma
5
Glioma
5
Central Nervous System Neoplasms
5
Uterine Cervical Neoplasms
4
Salivary Gland Neoplasms
4
Colorectal Neoplasms
4
Vulvar Neoplasms
3
Vaginal Neoplasms
3
Recurrence
3
Radiation Injuries
3
Pain
3
Ovarian Neoplasms
3
Fallopian Tube Neoplasms
3
Interventions
motexafin gadolinium
1
Talaporfin
1
Radiosurgery
1
Poly I-C
1
Gadolinium
1
Folfox protocol
1
Fluorouracil
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cisplatin
1
Bevacizumab
1
Anesthesia, General
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplasm Recurrence, Local
×
Radiosurgery
×
Clear all
NCT01594892
2019-09-04
DOSIS
Wuerzburg University Hospital
Phase NA
Completed
60 enrolled